Kay E. Sarji

510 total citations
14 papers, 406 citations indexed

About

Kay E. Sarji is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Kay E. Sarji has authored 14 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Hematology. Recurrent topics in Kay E. Sarji's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Blood properties and coagulation (3 papers) and Platelet Disorders and Treatments (3 papers). Kay E. Sarji is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Blood properties and coagulation (3 papers) and Platelet Disorders and Treatments (3 papers). Kay E. Sarji collaborates with scholars based in United States. Kay E. Sarji's co-authors include John A. Colwell, Julius Sagel, R.M.G. Nair, Jon H. Levine, P. V. Halushka, Robert H. Wagner, K. M. Brinkhous, Perry V. Halushka, J. González and Karl Eurenius and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Kay E. Sarji

14 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kay E. Sarji United States	10	122	117	111	74	67	14	406
Birgit Svensson Norway	14	191 1.6×	111 0.9×	169 1.5×	203 2.7×	49 0.7×	29	623
B C O'Malley United States	5	54 0.4×	111 0.9×	109 1.0×	52 0.7×	70 1.0×	7	345
Mar‐Lee McKean United States	6	74 0.6×	65 0.6×	49 0.4×	51 0.7×	41 0.6×	7	363
Daniel T. Price United States	5	147 1.2×	66 0.6×	204 1.8×	104 1.4×	65 1.0×	6	702
Makoto Hiramoto Japan	10	55 0.5×	58 0.5×	88 0.8×	102 1.4×	24 0.4×	14	400
Gary Peer Israel	7	134 1.1×	67 0.6×	131 1.2×	77 1.0×	33 0.5×	9	630
Arshia Panahloo United Kingdom	13	132 1.1×	246 2.1×	144 1.3×	79 1.1×	101 1.5×	20	572
Ying‐Tsung Chen Taiwan	14	65 0.5×	56 0.5×	245 2.2×	90 1.2×	50 0.7×	35	543
Takehiro Igawa Japan	10	40 0.3×	46 0.4×	211 1.9×	189 2.6×	68 1.0×	20	562
Guillermo Sáez Tormo Spain	5	128 1.0×	43 0.4×	81 0.7×	62 0.8×	107 1.6×	9	357

Countries citing papers authored by Kay E. Sarji

Since Specialization

Citations

This map shows the geographic impact of Kay E. Sarji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay E. Sarji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay E. Sarji more than expected).

Fields of papers citing papers by Kay E. Sarji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kay E. Sarji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay E. Sarji. The network helps show where Kay E. Sarji may publish in the future.

Co-authorship network of co-authors of Kay E. Sarji

This figure shows the co-authorship network connecting the top 25 collaborators of Kay E. Sarji. A scholar is included among the top collaborators of Kay E. Sarji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kay E. Sarji. Kay E. Sarji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

González, J., John A. Colwell, Kay E. Sarji, R.M.G. Nair, & Julius Sagel. (1980). Effect of metabolic control with insulin on plasma von willebrand factor activity (VIIIR:WF) in diabetes mellitus. Thrombosis Research. 17(1-2). 261–266. 18 indexed citations

Sarji, Kay E., et al.. (1979). Decreased platelet vitamin C in diabetes mellitus: Possible role in hyperaggregation. Thrombosis Research. 15(5-6). 639–650. 33 indexed citations

Sarji, Kay E., et al.. (1979). Abnormalities of platelet aggregation in sickle cell anemia presence of a plasma factor inhibiting aggregation by ristocetin. Thrombosis Research. 14(2-3). 283–297. 11 indexed citations

Colwell, John A., Perry V. Halushka, Kay E. Sarji, & Julius Sagel. (1978). Platelet Function and Diabetes Mellitus. Medical Clinics of North America. 62(4). 753–766. 51 indexed citations

Colwell, John A., Perry V. Halushka, Kay E. Sarji, & Julius Sagel. (1978). Rationale for Antiplatelet Agents in Diabetic Vascular Disease. Advances in experimental medicine and biology. 102. 243–256. 4 indexed citations

Sarji, Kay E., et al.. (1977). The effects of dopamine on human platelet aggregation, in vitro.. Journal of Pharmacology and Experimental Therapeutics. 200(2). 449–457. 21 indexed citations

Sarji, Kay E., Jon H. Levine, Mary Barnes, et al.. (1977). Relation of Growth Hormone and Von Willebrand Factor Activity. Thrombosis and Haemostasis. 1 indexed citations

Sarji, Kay E., Jon H. Levine, R.M.G. Nair, Julius Sagel, & John A. Colwell. (1977). RELATION BETWEEN GROWTH HORMONE LEVELS AND VON WILLEBRAND FACTOR ACTIVITY. The Journal of Clinical Endocrinology & Metabolism. 45(4). 853–856. 21 indexed citations

Colwell, John A., et al.. (1977). THE EFFECT OF ORAL GLUCOSE ON VON WILLEBRAND FACTOR ACTIVITY IN NORMAL AND DIABETIC SUBJECTS. Clinical Endocrinology. 6(6). 437–442. 6 indexed citations

10.

Sarji, Kay E., et al.. (1977). Heparin-induced platelet aggregation in burn patients. Thrombosis Research. 10(2). 291–299. 9 indexed citations

11.

Colwell, John A., P. V. Halushka, Kay E. Sarji, et al.. (1976). Altered platelet function in diabetes mellitus.. PubMed. 25(2 SUPPL). 826–31. 158 indexed citations

12.

Lopes‐Virella, Maria F., Kay E. Sarji, Gabriel Virella, & John A. Colwell. (1976). Platelet lipoproteins a comparative study with serum lipoproteins. Biochimica et Biophysica Acta (BBA) - Protein Structure. 439(2). 339–348. 1 indexed citations

13.

Sarji, Kay E., et al.. (1975). Von Willebrand factor activity in normal subjects: Sex difference and variability. Thrombosis Research. 7(6). 885–895. 13 indexed citations

14.

Sarji, Kay E., et al.. (1974). Nature of von Willebrand Factor: A New Assay and a Specific Inhibitor. Proceedings of the National Academy of Sciences. 71(8). 2937–2941. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact